Function Health Secures $450M Growth Financing to Scale Preventive Health Services

Function Health, a leading direct-to-consumer lab testing platform based in Austin, Texas, has secured $450 million in growth financing from General Catalyst’s Customer Value Fund. This substantial round of funding comes just eight months after the company raised $298 million in its Series B round, bringing its total capital raised to over $800 million since its launch in 2023.

The platform, which offers subscribers access to more than 160 different lab tests without requiring a doctor’s referral, aims to democratize health testing and provide personalized insights. Memberships start at $365 per year, allowing users to order comprehensive lab panels covering everything from hormones to heart health. The results are reviewed by physicians, providing members with actionable recommendations.

Function Health’s CEO, Jonathan Swerdlin, emphasized the company's mission: “Our health is upstream of everything we want in life. Most available healthcare focuses on acute issues, but we need more than that. Function is built for anyone who wants to be healthy and take control of their well-being.”

Market Trends and Competitive Landscape

The direct-to-consumer health market is rapidly expanding, driven by consumer demand for convenient, affordable, and personalized health services. According to a report by Grand View Research, the global direct-to-consumer healthcare market size was valued at $12.4 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 15.3% from 2023 to 2030.

Function Health’s latest funding round underscores the investor confidence in this segment. The company's unique value proposition-offering comprehensive lab tests without the need for a doctor’s referral-sets it apart from traditional healthcare providers. This approach aligns with the growing trend of preventive care and consumer empowerment in health management.

In May 2025, Function Health acquired Ezra, a provider of AI-powered medical imaging services, to further enhance its offerings. The integration of Ezra's technology will allow Function Health to provide more comprehensive health insights and better manage chronic conditions.

Investment Implications

The $450 million growth financing from General Catalyst’s Customer Value Fund is a significant vote of confidence in Function Health’s business model and market potential. This investment will likely be used to scale the company’s operations, expand its technology platform, and enhance user experience.

Key figures:

• Total capital raised: Over $800 million
• Latest funding round: $450 million
• Series B funding: $298 million
• Membership cost: Starting at $365 per year
• Number of lab tests available: More than 160

For investors, the growing demand for tech-enabled health services presents a compelling opportunity. Function Health’s focus on preventive care and direct-to-consumer access aligns with broader market trends and consumer preferences. However, the company will need to navigate regulatory challenges and competition from established healthcare providers.

As Function Health continues to expand its platform and integrate advanced technologies like AI, it is well-positioned to capture a significant share of the growing direct-to-consumer health market. The recent funding round positions the company for sustained growth and innovation in the years ahead.